Brigham and Women's Hospital is utilizing an AI solution that has received clearance from the FDA.
1 report, 1 independent
Updated Jul 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Brigham and Women's Hospital is utilizing an AI solution that has received clearance from the FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Brigham and Women's Hospital
hospital in Boston, Massachusetts, United States
Nothing else this week.
Related events
- Ro Khanna compared his AI regulatory proposal to the FDA model.
- BioPorto is seeking regulatory pathways and activating its first clinical site in collaboration with Massachusetts General Hospital.
- Systems underwent strong testing protocols and product testing standards for AI models were discussed.
- The US administration rejected a proposed FDA-style central AI regulator while acknowledging the need to compete with China in the AI race.
- A clinical study led by Dr. Swee Lay Thein is underway at the National Institutes of Health and is subject to oversight by the Food and Drug Administration.